JACKSONVILLE, Fla.--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) today issued a task force consensus statement outlining recommended clinical approaches to pump therapy for patients with type 1 (T1D) and insulin-requiring type 2 (T2D) diabetes mellitus.
The number of patients using insulin pumps in the U.S. has been reported to range from 350,000 to 515,000.
The consensus statement lauds the benefits of pumps versus multiple daily insulin injections in appropriate patients, including favorable differences in glycemic control based on A1c, greater improvements in quality-of-life measures and reductions in severe hypoglycemic episodes.
The statement also emphasizes the need for medical providers to offer a uniform and comprehensive patient training program, noting that optimal patient success in pump use is contingent upon proper education in the therapy’s use, ongoing re-education and skills testing, and frequent follow-up contact with their healthcare team. Such a training program should encompass the following:
The statement identifies the ideal insulin pump patient as one who:
“Even after more than three decades of insulin pump clinical use and the improvements that have occurred over time, there is no question that expert guidance is still necessary to ensure their safe and optimal use,” said task force chair Dr. George Grunberger, F.A.C.P., F.A.C.E. “Thus, this statement identifies what we feel are steps necessary to advance the proper use of these devices.”
The consensus statement is featured in Volume 20, Number 5, May 2014 issue of Endocrine Practice, AACE’s peer-reviewed journal. To review the complete statement, visit https://www.aace.com/files/insulin-pump-management-cs.pdf.
About the Journal
Endocrine Practice, the official journal of the American College of Endocrinology (ACE) and the American Association of Clinical Endocrinologists (AACE), is a peer-reviewed journal published twelve times a year. The Journal publishes the latest information in the treatment of diabetes, thyroid disease, obesity, growth hormone deficiency, sexual dysfunction and osteoporosis, and contains original articles, case reports, review articles, commentaries, editorials, visual vignettes, as well as classified and display advertising. Special issues of Endocrine Practice also include AACE clinical practice guidelines and other AACE/ACE white papers. Complete content is available on the Endocrine Practice Web site at www.endocrinepractice.org.
About the American Association of Clinical Endocrinologists (AACE)
The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in endocrinology, diabetes and metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. Visit our site at www.aace.com.
About the American College of Endocrinology (ACE)
The American College of Endocrinology (ACE) is the educational and scientific arm of the American Association of Clinical Endocrinologists (AACE). ACE is the leader in advancing the care and prevention of endocrine and metabolic disorders by: providing professional education and reliable public health information; recognizing excellence in education, research and service; promoting clinical research and defining the future of Clinical Endocrinology. For more information, please visit www.aace.com/college.
AACE Public & Media Relations
Glenn Sebold, 904-404-4122